Clinical Trials Browser

Recruiting × Interventional × Desmoid Tumors × Clear all

Desmoid Tumors

NCT07176689 2026-03-03

Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)

Phase 4 Recruiting

50 enrolled

Sarcoma

Desmoid Tumors

NCT04851119 2026-02-24

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Phase 1/2 Recruiting

147 enrolled

CNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

Carcinoma, Hepatocellular, Lymphoma, Non-Hodgkin, Melanoma, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Ewing, Osteosarcoma, Colorectal Neoplasms, Endometrial Neoplasms, Hepatoblastoma, Desmoid Tumors

NCT05111964 2026-02-04

SarcAblate

Phase NA Recruiting

10 enrolled

Sarcoma

Sarcoma, Desmoid Tumors

NCT05949099 2025-09-08

Study of Cryoablation and Nirogacestat for Desmoid Tumor

Phase 2 Recruiting

28 enrolled

Sarcoma

Desmoid Tumors

NCT05091255 2025-08-01

Cryotherapy in the Treatment of Desmoid Tumors

Phase NA Recruiting

94 enrolled

Sarcoma

Desmoid Tumors

Clinical Trials

A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)

Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

SarcAblate

Study of Cryoablation and Nirogacestat for Desmoid Tumor

Cryotherapy in the Treatment of Desmoid Tumors